Standard Dental Labs Announces Acquisition of BRLIT Dental Laboratory, Inc. GlobeNewswire February 02, 2026 ORLANDO, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) — Standard Dental Labs Inc. (“SDL”), a Florida-based dental laboratory platform focused on high-quality clinical outcomes and long-term practitioner relationships, today announced that it has completed the acquisition of BRLIT Dental Laboratory, Inc., a […]

Infosys named official entitlement partner of iconic Theater at MSG – now the Infosys Theater at Madison Square Garden Infosys will continue to elevate fan engagement for the New York Knicks and the New York Rangers Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, Madison Square Garden

Mwyngil Therapeutics, a clinical-stage biopharmaceutical company focused on immunometabolic and neuroinflammatory diseases, today announced the initiation of a Phase 1 clinical study of BT-409, a potentially best-in-class, brain-permeable NLRP3 inhibitor being developed for multiple sclerosis (MS), Parkinson’s disease (PD), and other neuroinflammatory indications. BT-409 has been partnered to and is being clinically developed by Brenig

Ubertrends LLC today announced the launch of Solo Trillion (SoloTrillion.com), a new operator-focused platform covering the fast-emerging world of agentic AI. Positioned as a “living lab,” Solo Trillion publishes practical field reports, tool experiments, implementation notes, and reviews that prioritize execution outcomes over marketing claims. The site addresses the shift from AI that advises to

New collaborations with Spectrum Technologies and Watertronics strengthen Rain Bird’s commitment to data-driven course management Rain Bird Corporation today announced new partnerships with Spectrum Technologies and Watertronics, expanding the company’s growing portfolio of soil data and pump monitoring solutions for golf course superintendents. These new collaborations will allow golf courses of all types and sizes

(NASDAQ:SPRC), NeuroThera's Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a

SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA GlobeNewswire February 02, 2026 NeuroThera's Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”),

Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – Prophecy DeFi Inc. (CSE: PDFI) (“Prophecy DeFi” or the “Company“) is pleased to announce it intends to raise up to $600,000 through the issuance of up to 5,000,000 units (the “Units“) at a price of $0.12 per Unit in a non-brokered private placement financing (the “Private Placement“).

Cyclotron unveils its new Strategy Office: A bold advisory powerhouse launching with a dedicated focus on AI and designed to help enterprises cut through the noise, reduce risk, and accelerate meaningful innovation. With expert guidance spanning from strategic clarity and alignment to enterprise?grade AI engineering and delivery, this launch signals a transformative new era for

Recognition aligns with strong fundraising activity and new fund launch in 2025 Manulife Investment Management (Manulife IM) announced today that it has been named a leader in IPE Real Assets’ list of Top 50 Natural Capital Managers.1 The publication highlighted the strength of the firm’s combined timberland and agriculture platform at EUR 13.8B AUM, which